According to the report, one of the labs at the University of Wisconsin, Madison, will resume testing in a few weeks after researchers received a grant from the National Institutes of Health’s (NIH’s) National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland.
Office of Strategic Communication